Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PDSB | AZN | AMGN | GILD | BMY |
| Company | Pds Biotechnology Corp | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 1.0200 | 186.69 | 330.75 | 131.36 | 58.67 |
| High | 1.1100 | 188.23 | 331.95 | 131.95 | 59.21 |
| Low | 1.0100 | 185.73 | 326.80 | 129.49 | 58.11 |
| Latest | 1.0800 | 187.49 | 330.79 | 130.33 | 58.33 |
| Change | +0.0800 | +2.85 | +0.04 | -0.17 | +0.02 |
| % Change | +8.00% | +1.54% | +0.01% | -0.13% | +0.03% |
| Volume | 446,264 | 875,524 | 1,325,476 | 1,879,661 | 2,298,101 |
| 20-Day Average Volume | 1,031,011 | 2,015,016 | 2,682,030 | 5,971,558 | 10,025,697 |
| Previous Close | 1.0000 | 184.64 | 330.75 | 130.50 | 58.31 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.1016 | 185.26 | 334.17 | 131.68 | 57.49 |
| 20-Day Raw Stochastic | 33.13% | 44.35% | 34.72% | 24.54% | 55.16% |
| 20-Day Relative Strength | 51.13 | 47.78 | 43.78 | 42.21 | 51.71 |
| Weighted Alpha | -47.19 | +27.47 | +16.33 | +16.44 | +25.59 |
| Today's Opinion | 64% Buy | 8% Buy | 24% Sell | 24% Sell | 40% Buy |
| Previous Opinion | 48% Buy | 24% Sell | 24% Sell | 24% Sell | 40% Buy |
| Last Month's Opinion | 24% Buy | 64% Buy | 24% Buy | 24% Buy | 64% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -18.12% since 05/13/26 | -0.18% since 05/13/26 | -1.62% since 05/13/26 | -2.25% since 05/13/26 | +3.51% since 05/13/26 |
| Low | 1.0000 on 05/19/26 | 180.55 on 05/15/26 | 320.96 on 05/19/26 | 128.34 on 05/19/26 | 56.10 on 05/14/26 |
| High | 1.5500 on 05/14/26 | 188.23 on 05/20/26 | 337.94 on 05/14/26 | 134.65 on 05/14/26 | 59.21 on 05/20/26 |
| 1-Month | |||||
| %Chg | -15.58% since 04/20/26 | -6.63% since 04/20/26 | -5.47% since 04/20/26 | -4.28% since 04/20/26 | -1.29% since 04/20/26 |
| Low | 0.8606 on 04/24/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 1.5500 on 05/14/26 | 198.99 on 04/21/26 | 350.69 on 04/23/26 | 137.50 on 05/12/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | +68.06% since 02/20/26 | -8.24% since 02/20/26 | -11.68% since 02/20/26 | -14.10% since 02/20/26 | -3.78% since 02/20/26 |
| Low | 0.5068 on 03/31/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 1.5500 on 05/14/26 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 152.46 on 02/23/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +44.03% since 11/20/25 | +5.65% since 11/20/25 | -1.51% since 11/20/25 | +4.06% since 11/20/25 | +27.06% since 11/20/25 |
| Low | 0.5068 on 03/31/26 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.52 on 11/21/25 |
| High | 1.5500 on 05/14/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 55,816 | 286,359,648 | 178,500,816 | 162,024,880 | 119,073,168 |
| Shares Outstanding, K | 55,816 | 1,550,908 | 539,685 | 1,241,570 | 2,042,071 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -34,500,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -7,350,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 1.51 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.13 on 05/13/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 08/12/26 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.86 | 14.68 | 15.49 | 9.66 |